Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upholding science in health, safety and environmental risk assessments and regulations.
Aschner M, Autrup HN, Berry SC, Boobis AR, Cohen SM, Creppy EE, Dekant W, Doull J, Galli CL, Goodman JI, Gori GB, Greim HA, Joudrier P, Kaminski NE, Klaassen CD, Klaunig JE, Lotti M, Marquardt HW, Pelkonen O, Sipes IG, Wallace KB, Yamazaki H. Aschner M, et al. Among authors: marquardt hw. Toxicology. 2016 Sep 14;371:12-16. doi: 10.1016/j.tox.2016.09.005. Epub 2016 Sep 14. Toxicology. 2016. PMID: 27639665 Free article.
Whither the impending european regulation of presumed endocrine disruptors?
Autrup HN, Berry SC, Cohen SM, Creppy EE, de Camargo JL, Dekant W, Dietrich D, Galli CL, Goodman JI, Gori GB, Greim HA, Klaunig JE, Lotti M, Marquardt HW, Wallace KB, Yamazaki H. Autrup HN, et al. Among authors: marquardt hw. Regul Toxicol Pharmacol. 2016 Dec;82:A1-A2. doi: 10.1016/j.yrtph.2016.09.006. Epub 2016 Sep 9. Regul Toxicol Pharmacol. 2016. PMID: 27615676 No abstract available.
Obfuscating transparency?
Aschner M, Autrup H, Berry CL, Boobis AR, Cohen SM, Dekant W, Galli CL, Goodman JI, Gori GB, Greim HA, Kaminski NE, Klaassen CD, Klaunig JE, Lotti M, Marquardt HW, Moretto A, Pelkonen O, Sipes IG, Wallace KB, Yamazaki H. Aschner M, et al. Among authors: marquardt hw. Regul Toxicol Pharmacol. 2018 Aug;97:A1-A3. doi: 10.1016/j.yrtph.2018.07.004. Epub 2018 Jul 11. Regul Toxicol Pharmacol. 2018. PMID: 30017904
The EU chemicals strategy for sustainability: in support of the BfR position.
Barile FA, Berry SC, Blaauboer B, Boobis A, Bolt HM, Borgert C, Dekant W, Dietrich D, Domingo JL, Galli CL, Gori GB, Greim H, Hengstler JG, Heslop-Harrison P, Kacew S, Marquardt H, Mally A, Pelkonen O, Savolainen K, Testai E, Tsatsakis A, Vermeulen NP. Barile FA, et al. Arch Toxicol. 2021 Sep;95(9):3133-3136. doi: 10.1007/s00204-021-03125-w. Epub 2021 Aug 7. Arch Toxicol. 2021. PMID: 34363510 Free PMC article.
Editorial.
Wallace KB, Marquardt HW. Wallace KB, et al. Among authors: marquardt hw. Toxicology. 2016 Sep 14;371:A1. doi: 10.1016/j.tox.2016.06.014. Epub 2016 Jul 2. Toxicology. 2016. PMID: 27381659 No abstract available.
Editorial.
Aschner M, Autrup HN, Cohen SM, Dekant W, Eisenbrand G, Galli CL, Gori GB, Kaminski NE, Klaassen CD, Klaunig JE, Levy L, Lotti M, Marquardt HW, Pelkonen O, Schrenk DF, Yamazaki H. Aschner M, et al. Among authors: marquardt hw. Regul Toxicol Pharmacol. 2019 Feb;101:A1-A2. doi: 10.1016/j.yrtph.2018.12.015. Regul Toxicol Pharmacol. 2019. PMID: 30642615 No abstract available.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Toxicol Lett. 2020 Oct 1;331:259-264. doi: 10.1016/j.toxlet.2020.04.008. Epub 2020 Apr 30. Toxicol Lett. 2020. PMID: 32360654 No abstract available.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Hengstler J, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Food Chem Toxicol. 2020 Aug;142:111349. doi: 10.1016/j.fct.2020.111349. Epub 2020 Apr 30. Food Chem Toxicol. 2020. PMID: 32360905
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Environ Toxicol Pharmacol. 2020 Aug;78:103396. doi: 10.1016/j.etap.2020.103396. Epub 2020 Apr 29. Environ Toxicol Pharmacol. 2020. PMID: 32391796
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Arch Toxicol. 2020 Jul;94(7):2549-2557. doi: 10.1007/s00204-020-02800-8. Epub 2020 Jun 8. Arch Toxicol. 2020. PMID: 32514609 Free PMC article.
82 results